Brooke Sutherland, Columnist

Crouching Tiger, Hidden FMC

FMC is in a good position to scoop up the assets its larger rivals divest as they consolidate.

August 1, 2016 at 12:00 PM UTC

Brooke Sutherland is Bloomberg News' Boston bureau chief and writes the Industrial Strength Newsletter. She was previously a Bloomberg Opinion columnist covering deals and industrial companies and an M&A reporter for Bloomberg News.

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

While its biggest rivals compete for deals, insecticide maker FMC Corp. is biding its time.

You'd think its digestible $6.4 billion market value would make it an easy target at a time when just about everyone in the industry is drawing interest. (Quick recap: Dow and DuPont are merging, ChemChina is buying Syngenta and Monsanto, Bayer and BASF all seem to be holding deal talks of one sort or another.) But FMC's name hasn't come up much.